| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6149189 | Archives of Medical Research | 2013 | 5 Pages |
Abstract
Pravastatin significantly reduced serum levels of CRP and total and LDL-cholesterol compared to placebo. This treatment may be of great help to decrease the inflammatory status and probably the cardiovascular disease of CAPD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Alfonso M. Cueto-Manzano, Juan R. Ángel-Zúñiga, Gabina Ornelas-Carrillo, Enrique Rojas-Campos, Héctor R. MartÃnez-RamÃrez, Laura Cortés-Sanabria,